Skip to content

Propulsion Surveys

Propulsion Survey: Image of a rocket flying out of an open laptop.

Our goal with these surveys is to PROPEL RESEARCH FORWARD in collaboration with institutions of excellence or pharmaceutical companies with a solid dedication to understanding the MOGAD patient community for whom they create therapeutic treatments.

These surveys rise above the level of our other surveys in that they are designed to lead to published posters and studies that ensure the results are known to the medical communities working to understand rarae neuroimmune disorders of the central nervous system.

Special thanks to the members of the MOGAD community and their caregivers for participating in this survey.


Our current survey is waiting for approval in publication
Stay tuned for results to be posted here shortly
all Winners of the MOG Gear Drawing have Been selected

In collaboration with Johns Hopkins Neurology Department, this survey was developed to give researchers a clearer idea of patient diagnosis experience and quality of life post MOGAD.  We invited all MOGAD patients globally to join this internal review board (IRB) certified survey to let their voices be heard.  This survey is designed with patient experience in mind and will help researchers better understand your stories as they relate to disease impact.

We thank this great MOGAD Community for the valuable participation!
Propel research in MOGAD forward by participating in our Propulsion Survey. Diagnosis Experience and quality of life off MOGAD Patients. The MOG Project and Johns Hopkins Medicine Logos. Image of a hand holding a launching rocket.

Select the image for the results of our first Propulsion Survey

Propel Research in MOGAD by participating in our survey. Patient Experience. Dr. Jon Santoro, The MOG Project Logo and UCB Pharma.

Propulsion Survey #1

This survey was done in collaboration with Dr. Jonathan Santoro from University of Southern California and UCB Biopharma. It focused on the patient pathway from the first signs of disease onset to diagnosis and the impact on patients as a result of their experince.